Weight Loss Medications: Comparing Top Options

Comparing Mounjaro and Ozempic for weight loss? Learn how these GLP-1 agonists work, their effectiveness, side effects, and find the right option for you!

5 min read
459 views
Medically Reviewed
Photo of Dr. Muhammad Ahmed

Dr. Muhammad Ahmed

Paediatrician | GMC: 8011301
Reviewed on:

Dr. Muhammad Ahmed is a passionate paediatrician dedicated to providing exceptional care to children.

Unread
Featured image for Weight Loss Medications: Comparing Top Options

Weight loss medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) have gained popularity for their effectiveness in managing obesity. This guide explores their mechanisms, weight loss results, side effects, and eligibility to help you decide which might be right for you.

Glucagon-like peptide-1 (GLP-1) is currently one of the most promising biological systems for the development of effective obesity pharmacotherapies. Long-acting GLP-1 analogs potently reduce food intake and body weight, and recent discoveries reveal that peripheral administration of these drugs reduces food intake largely through humoral pathways involving direct action on brain GLP-1 receptors (GLP-1R).

Mounjaro vs Ozempic: Which Works Better?

Mounjaro uses a dual-action mechanism on GIP and GLP-1 receptors, while Ozempic targets only GLP-1 receptors, leading to differences in effectiveness. Clinical studies show that Mounjaro may be more effective than Ozempic in managing blood sugar levels and promoting weight loss. Ozempic is approved to reduce the risks of major cardiovascular events and complications from kidney disease, a benefit not shared by Mounjaro. Both medications are long-term injectable treatments for Type 2 diabetes that are meant to be used alongside lifestyle changes like a balanced diet and exercise.

Wegovy or Saxenda: Which Delivers Greater Weight Loss?

Understandably, most people who are choosing between weight loss treatments want to know which option will be the most effective. Although results will vary depending on your starting weight, lifestyle and diet, Wegovy is generally considered to be more effective than Saxenda. One 68-week study showed that almost half of adults (48%) taking Wegovy lost around 15% of their starting body weight. Wegovy is now one of the best known and most popular weight loss medications. If you take Wegovy injections, improve your diet and increase the amount of exercise you do, you could lose up to 15% of your starting body weight in the first year of treatment.

The active ingredient in Wegovy is Semaglutide. This mimics a hormone called GLP-1 that is naturally produced by your body and acts on receptors in the brain to tell you you are full. By mimicking this hormone, Semaglutide can trigger the GLP-1 receptor and trick your body into thinking you are not hungry. This may reduce your appetite and make fatty and sugary foods – which are usually high in calories – less tempting.

Saxenda contains an active ingredient called Liraglutide. This also acts on the GLP-1 receptor to shrink your appetite and help stop overeating. Research has shown that Saxenda, combined with increased exercise and an improved diet, could help you lose between 5% and 10% of your starting body weight in the first year of treatment.

Mysimba vs other weight loss drugs

Mysimba (naltrexone/bupropion) is a weight-loss medication that differs from other options like Semaglutide (Wegovy, Ozempic) and Liraglutide (Saxenda) in its mechanism of action, side effects, and effectiveness. Mysimba is a combination medication that affects brain chemistry to reduce appetite and increase energy expenditure, while GLP-1 receptor agonists like Semaglutide and Liraglutide work by mimicking a hormone in the gut that regulates appetite and blood sugar

Mysimba (Naltrexone-bupropion) significantly reduces body weight by a small amount but significantly increases the risk of side effects. A rigorous process of post marketing surveillance is required. Key Differences are:

Mechanism of Action

Mysimba acts on the brain, while GLP-1 receptor agonists act on the gut.

Potential Side Effects

While both have similar gastrointestinal side effects, Mysimba may have a higher risk of psychiatric side effects.

Weight Loss Results

GLP-1 receptor agonists generally show greater weight loss results than Mysimba.

The Science Behind GLP-1 Agonists and Weight Loss

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity. As a class of medications, they are among several pharmacological options for these endocrine diseases. The function of GLP-1 agonists is to lower serum glucose levels and thereby manage metabolism in affected patients.

How do GLP-1 agonists work?

To understand how GLP-1 agonists work, it helps to understand how the naturally occurring GLP-1 hormone works. GLP-1 is a hormone that small intestine makes. It has several roles, including:

GLP-1 (glucagon-like peptide-1) plays a crucial role in regulating blood sugar and appetite. It triggers insulin release from the pancreas, helping the body convert food into energy while lowering blood glucose levels, insufficient insulin can lead to high blood sugar and diabetes. At the same time, GLP-1 blocks glucagon secretion, preventing excess glucose from entering the bloodstream. Additionally, it slows stomach emptying, reducing the rate at which glucose from food is absorbed. Beyond blood sugar control, GLP-1 enhances satiety by acting on brain regions that process hunger signals, helping people feel fuller longer after eating. These combined effects make GLP-1 a key target for diabetes and weight management medications.

Consideration of weight loss medication

  • BMI equal or greater than 30.
  • BMI equal or greater than 27 with one or more obesity-related conditions (like high blood pressure or diabetes)
  • Have not lost at least 5% of their total body weight in three to six months with lifestyle changes alone.

Medications like Mounjaro, Ozempic, Wegovy, Saxenda, and Mysimba work through different mechanisms, such as GLP-1 receptor activation or brain chemistry modulation to aid weight loss when combined with lifestyle changes. A healthcare provider can assess individual health factors to determine the most suitable option.

Expected Weight Loss

How much weight you can safely lose in a month varies from person to person. However, most health experts and medical organizations recommend a weight loss goal of 1-2 pounds, or lbs (2.2-4.4 kilograms, or kg) per week, which equates to 4-8 lbs (8.8-17.6 kg) per month. This pace helps reduce the risk of complications and improves your chances of keeping the weight off long-term.

Disclaimer

The information in this article is intended for informational purposes and not as a substitute for professional medical advice. Always consult a physician or other qualified healthcare provider for specific questions about your health.

Share this article

Frequently Asked Questions

Common questions about Weight Loss Medications: Comparing Top Options

GLP-1 drugs like Ozempic and Wegovy work by slowing digestion, reducing hunger signals in the brain, and improving insulin sensitivity. These effects help feel full longer, eat less, and better regulate blood sugar, leading to gradual, sustained weight loss.

Most people lose 1025% of their body weight over 12+ months when combined with diet and exercise. Results vary based on individual factors like starting weight, metabolism, and adherence to lifestyle changes.

Adults with a BMI ≥30 (obesity) or ≥27 (overweight) with weight-related conditions (like diabetes or high blood pressure) may qualify. A doctor will assess medical history before prescribing.

Nausea, diarrhea, and constipation are most common but often improve over time. Rare but serious risks include pancreatitis and gallbladder issues prompt medical attention is needed if severe symptoms occur.

Since obesity is a chronic condition, long-term use is often necessary. Stopping treatment may lead to weight regaining, so ongoing management with lifestyle changes is recommended.

Test Your Knowledge

Challenge yourself with our interactive quiz!

Weight Loss Medications: Understanding Your Options

Show Feedback:
At the end Instant
Timer:
1 / 8

GLP-1 medications help with weight loss by reducing appetite and increasing feelings of fullness.

GLP-1 medications help with weight loss by reducing appetite and increasing feelings of fullness.
GLP-1 medications act on the brain and digestive system to reduce hunger and enhance satiety.
GLP-1 medications are known for their appetite-regulating and satiety-enhancing effects.

Which medication works on both GIP and GLP-1 receptors, giving it a dual-action mechanism?

Which medication works on both GIP and GLP-1 receptors, giving it a dual-action mechanism?
Mounjaro targets both GIP and GLP-1 receptors, which may enhance its metabolic effects.
Only one option uses a dual-hormone mechanism.

Which image best represents how GLP-1 medications support weight loss?

GLP-1 medications promote satiety, helping people feel full for longer after eating.
GLP-1 medications work by regulating appetite, not by surgery or rapid weight changes.

Wegovy and Ozempic contain the same active ingredient but are approved for different uses.

Wegovy and Ozempic contain the same active ingredient but are approved for different uses.
Both medications contain semaglutide, but they are approved for different indications.
The active ingredient is the same, even though the approved uses differ.

Which medication is associated with 5–10% weight loss over the first year when combined with diet and exercise?

Which medication is associated with 5–10% weight loss over the first year when combined with diet and exercise?
Studies show Saxenda may help people lose around 5–10% of body weight over a year.
Some medications are associated with greater average weight loss.

Mysimba primarily works by mimicking gut hormones that slow digestion.

Mysimba primarily works by mimicking gut hormones that slow digestion.
Mysimba affects brain chemistry related to appetite and reward, not gut hormones.
Gut hormone mimicry is a feature of GLP-1 medications, not Mysimba.

Who may qualify for prescription weight loss medications according to common guidelines?

Who may qualify for prescription weight loss medications according to common guidelines?
Eligibility often depends on BMI, health conditions, and response to lifestyle changes.
Multiple factors are considered when determining eligibility.

Weight loss medications are usually most effective when combined with healthy eating and regular physical activity.

Weight loss medications are usually most effective when combined with healthy eating and regular physical activity.
Medications are intended to support, not replace, lifestyle changes.
Lifestyle habits play a key role in long-term weight management.
0 %

Quiz Completed!

0 Correct
0 Incorrect
8 Questions
Share this Quiz!
Link copied!

    References & Sources

    Navigate this article